Abstracts tagged "Depression and systemic lupus erythematosus (SLE)"

Abstract Number: 742 • 2018 ACR/ARHP Annual Meeting
Moderate to Severe Depression in Patients with Systemic Lupus Erythematosus
Nathalie Chalhoub and Michael Luggen, Division of Immunology, Allergy, and Rheumatology, University of Cincinnati College of Medicine, Cincinnati, OH
Background/Purpose: Depression is among the most common neuropsychiatric manifestations in SLE with a prevalence reported to be up to 75% in some studies. Depression in…
Abstract Number: 770 • 2018 ACR/ARHP Annual Meeting
Cognitive Function Trajectories Are Associated with the Depressive Symptoms Trajectories in SLE over Time
Zahi Touma¹, Jiandong Su¹ and Patricia Katz², ¹University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²University of California San Francisco, San Francisco, CA
Background/Purpose: We have shown that cognitive function followed particular trajectories over time in SLE, with some patients having persistently low scores and others normal scores.…
Abstract Number: 2342 • 2018 ACR/ARHP Annual Meeting
A Pan-Canadian Study of Factors Associated with Perceived Doctor-Patient Communication in Patients with Systemic Lupus Erythematosus
Deborah Da Costa¹, Carolyn Neville², Anne-Sophie Julien³, Murray Rochon⁴, Davy Eng⁵, Christine A. Peschken⁶, Evelyne Vinet⁷, C Douglas Smith⁸, Mark Matsos⁹, Janet E. Pope¹⁰, Ann E. Clarke¹¹, Stephanie Keeling¹², J. Antonio Avina-Zubieta¹³, Marie Hudson¹⁴ and Paul R. Fortin¹⁵, ¹Medicine, McGill University, Montreal, QC, Canada, ²Department of Medicine, McGill University Health Center, Montreal, QC, Canada, ³CHU de Québec - Université Laval, Quebec City, QC, Canada, ⁴Jack Digital, Toronto, ON, Canada, ⁵Centre de recherche du CHU de Québec, Université Laval, Québec, QC, Canada, ⁶RR 149G, University of Manitoba, Winnipeg, MB, Canada, ⁷Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, ⁸The Arthritis Centre, TOH Riverside Campus, Ottawa, ON, Canada, ⁹Medicine, McMaster University, Hamilton, ON, Canada, ¹⁰Department of Medicine, University of Western Ontario, London, ON, Canada, ¹¹Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, ¹²Department of Medicine, University of Alberta, University of Alberta, Edmonton, AB, Canada, ¹³Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada, ¹⁴Division of Rheumatology, Jewish General Hospital, Lady Davis Institute for Medical Research, Montreal, QC, Canada, ¹⁵Medicine, CHU de Québec - University of Laval, Quebec, QC, Canada
Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with fluctuating levels of disease activity, which may require frequent encounters with the medical system…
Abstract Number: 1595 • 2017 ACR/ARHP Annual Meeting
Prevalence and Predictors of Depression in Patients with Systemic Lupus Erythematosus: Results from the Korean Lupus Network (KORNET) Registry
Kyung-Eun Lee¹, Ji-Hyoun Kang², Dong-Jin Park² and Shin-Seok Lee², ¹Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South), ²Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South)
Background/Purpose: Depression is more common in patients with systemic lupus erythematosus (SLE) than in the general population. However, few studies have investigated predictors of depression…
Abstract Number: 1771 • 2016 ACR/ARHP Annual Meeting
Depression Is Associated with a Poorer with Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus
Yelitza Cecilia Velarde-Mejia¹, Manuel Ugarte-Gil^1,2, Rocio V. Gamboa-Cardenas¹, Francisco Zevallos¹, Mariela Medina¹, Jorge M. Cucho-Venegas¹, José Alfaro¹, Zoila Rodriguez-Bellido^1,3, Cesar A. Pastor-Asurza^1,3 and Risto Perich-Campos^1,3, ¹Rheumatology, Hospital Guillermo Almenara Irigoyen. EsSalud, Lima, Peru, ²Universidad Cientifica del Sur, Lima, Peru, ³Universidad Nacional Mayor de San Marcos, Lima, Peru
Background/Purpose: Systemic lupus erythematosus (SLE) is a complex autoimmune disease with frequent involvement of the central nervous system. Among the items included in the nomenclature…
Abstract Number: 2117 • 2014 ACR/ARHP Annual Meeting
Association Between Depression and High Utilization of Emergency Department in Patients with Systemic Lupus Erythematosus from the Southeastern United States: The Goal Cohort
Alfredo Aguirre¹, S. Sam Lim², Gaobin Bao³, Charles T. Molta⁴, Hong Kan⁵ and Cristina Drenkard⁶, ¹Department of Rheumatology, Emory University, Atlanta, GA, ²Emory University School of Medicine, Division of Rheumatology, Atlanta, GA, ³Medicine, Emory University, Atlanta, GA, ⁴GlaxoSmithKline, King of Prussia, PA, ⁵5 Moore Dr, GSK, Durham, NC, ⁶Medicine, Div Rheumatology, Emory University, Atlanta, GA
Background/Purpose . Frequent visitors of the emergency department (ED) among the general population share several demographic, health system and disease characteristics, including older age, poverty,…
Abstract Number: 1589 • 2013 ACR/ARHP Annual Meeting
Obesity and Vascular Factors May Play a Role In Persistent Depression Among Individuals With Systemic Lupus Erythematosus
Patricia P. Katz¹, Chris Tonner¹, Laura Trupin¹, Edward H. Yelin² and Jinoos Yazdany¹, ¹Medicine, University of California, San Francisco, San Francisco, CA, ²Medicine, UC San Francisco, San Francisco, CA
Background/Purpose: Depression is commonly reported in systemic lupus erythematosus (SLE), yet information is lacking about long-term patterns of depression. In particular, because depression is thought…
Abstract Number: 906 • 2013 ACR/ARHP Annual Meeting
Longitudinal Patterns Of Depression In Lupus
Patricia P. Katz, Chris Tonner, Laura Trupin and Jinoos Yazdany, Medicine, University of California, San Francisco, San Francisco, CA
Background/Purpose: Depression is commonly reported in systemic lupus erythematosus (SLE), yet information is lacking about long-term patterns of depression. We examined a longitudinal SLE cohort…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].